Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05892_nanopub.RARnwrLi1HliZQ3vIq_TRwNltnfdXWduqcZ18-EPDIdps#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05892 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05892 label "RI 624 [drugbank:DB05892]" assertion.
- drugbank:DB05892 seeAlso DB05892 assertion.
- drugbank:DB05892 description "RI 624 is a novel humanized monoclonal antibody that blocks nerve growth factor (NGF), a key mediator of acute and chronic pain. RI 624 is being developed by Rinat and is currently in Phase I clinical trials." assertion.
- drugbank:DB05892 identifier "drugbank:DB05892" assertion.
- drugbank:DB05892 title "RI 624" assertion.
- drugbank:DB05892 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05892 drugbank_vocabulary:drugbank-id "DB05892" assertion.
- drugbank:DB05892 bio2rdf_vocabulary:x-identifiers.org DB05892 assertion.
- drugbank:DB05892 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05892" assertion.
- drugbank:DB05892 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05892 bio2rdf_vocabulary:identifier "DB05892" assertion.